BIOMAT Database Logo BIOMAT Database Logo

[Proteolytic enzyme inhibitor and the kinin system in thyrotoxicosis]. 1982

V P Fesenko, and V A Protsenko, and A K Babalich, and A V Protsenko, and V F Veselov

Free bradykinin, kininogen, kininase, protease inhibitors of alpha 1-antitrypsin, alpha 1-antichymotrypsin, alpha 2-macroglobulin, and antitryptic volume of the blood serum were examined in 25 patients suffering from goiter with thyrotoxicosis symptoms. Activation of the kinin system and reduction in the antitryptic volume were revealed before the operation. The level of the rest inhibitors was elevated. After operative intervention these changes became more expressed. alpha 2-Macroglobulin content increased. By the moment of discharge the above parameters tended to normalization. The content of the majority of inhibitors, however, did not reach normal. This should be taken into consideration during rehabilitation of patients with thyrotoxicosis.

UI MeSH Term Description Entries
D006980 Hyperthyroidism Hypersecretion of THYROID HORMONES from the THYROID GLAND. Elevated levels of thyroid hormones increase BASAL METABOLIC RATE. Hyperthyroid,Primary Hyperthyroidism,Hyperthyroidism, Primary,Hyperthyroids
D007705 Kinins A generic term used to describe a group of polypeptides with related chemical structures and pharmacological properties that are widely distributed in nature. These peptides are AUTACOIDS that act locally to produce pain, vasodilatation, increased vascular permeability, and the synthesis of prostaglandins. Thus, they comprise a subset of the large number of mediators that contribute to the inflammatory response. (From Goodman and Gilman's The Pharmacologic Basis of Therapeutics, 8th ed, p588) Kinin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011184 Postoperative Period The period following a surgical operation. Period, Postoperative,Periods, Postoperative,Postoperative Periods
D011480 Protease Inhibitors Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). Antiprotease,Endopeptidase Inhibitor,Endopeptidase Inhibitors,Peptidase Inhibitor,Peptidase Inhibitors,Peptide Hydrolase Inhibitor,Peptide Hydrolase Inhibitors,Peptide Peptidohydrolase Inhibitor,Peptide Peptidohydrolase Inhibitors,Protease Antagonist,Protease Antagonists,Antiproteases,Protease Inhibitor,Antagonist, Protease,Antagonists, Protease,Hydrolase Inhibitor, Peptide,Hydrolase Inhibitors, Peptide,Inhibitor, Endopeptidase,Inhibitor, Peptidase,Inhibitor, Peptide Hydrolase,Inhibitor, Peptide Peptidohydrolase,Inhibitor, Protease,Inhibitors, Endopeptidase,Inhibitors, Peptidase,Inhibitors, Peptide Hydrolase,Inhibitors, Peptide Peptidohydrolase,Inhibitors, Protease,Peptidohydrolase Inhibitor, Peptide,Peptidohydrolase Inhibitors, Peptide
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D005260 Female Females
D005779 Immunodiffusion Technique involving the diffusion of antigen or antibody through a semisolid medium, usually agar or agarose gel, with the result being a precipitin reaction. Gel Diffusion Tests,Diffusion Test, Gel,Diffusion Tests, Gel,Gel Diffusion Test,Immunodiffusions,Test, Gel Diffusion,Tests, Gel Diffusion
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

V P Fesenko, and V A Protsenko, and A K Babalich, and A V Protsenko, and V F Veselov
[State of the kallikrein-kinin system in thyrotoxicosis].
February 1980, Vrachebnoe delo,
V P Fesenko, and V A Protsenko, and A K Babalich, and A V Protsenko, and V F Veselov
Kinin formation and inactivation by alcalase, a proteolytic enzyme.
November 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
V P Fesenko, and V A Protsenko, and A K Babalich, and A V Protsenko, and V F Veselov
[Blood kallikrein-kinin systems and proteolytic enzyme activity in acute cerebrovascular disorders].
January 1984, Klinicheskaia meditsina,
V P Fesenko, and V A Protsenko, and A K Babalich, and A V Protsenko, and V F Veselov
Responses of the renin-angiotensin system and kallikrein-kinin system to sodium and converting enzyme inhibitor (SQ 14,225).
January 1979, Advances in experimental medicine and biology,
V P Fesenko, and V A Protsenko, and A K Babalich, and A V Protsenko, and V F Veselov
The kinin-forming enzyme system in pregnancy and obstetrical DIC.
January 1983, Bibliotheca haematologica,
V P Fesenko, and V A Protsenko, and A K Babalich, and A V Protsenko, and V F Veselov
Angiotensin-converting enzyme inhibitors and the kallikrein-kinin system.
January 1990, Journal of cardiovascular pharmacology,
V P Fesenko, and V A Protsenko, and A K Babalich, and A V Protsenko, and V F Veselov
Plasma-kinin-forming enzyme in human skin: extraction and column chromatographic separation of plasma-kinin-forming enzyme and its inhibitor.
January 1978, Acta dermato-venereologica,
V P Fesenko, and V A Protsenko, and A K Babalich, and A V Protsenko, and V F Veselov
Proteolytic enzyme system in sexual deviates.
September 1954, A.M.A. archives of neurology and psychiatry,
V P Fesenko, and V A Protsenko, and A K Babalich, and A V Protsenko, and V F Veselov
Modulation of the kallikrein/kinin system by the angiotensin-converting enzyme inhibitor alleviates experimental autoimmune encephalomyelitis.
November 2014, Clinical and experimental immunology,
V P Fesenko, and V A Protsenko, and A K Babalich, and A V Protsenko, and V F Veselov
Vinyl sulfonium as novel proteolytic enzyme inhibitor.
September 2001, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!